聚合搜Scholar - 壹搜网为您找到"

别再滥用 ClickHouse 了!单机每秒狂刷 1800 万条数据,拆解 Go+DuckDB 的“微型数仓”降维打击

"相关结果 10条

At the extreme limits of L-DOPA therapy: probable dopamine dysregulation and psychiatric complications in Parkinson's disease.

Dopamine dysregulation syndrome (DDS) is an uncommon but debilitating complication of Parkinson's disease (PD), characterised by a compulsive overuse of dopaminergic therapy. Most reported cases are male and involve daily oral levodopa (L-DOPA) intake between 2000 and 4000 mg.
www.ncbi.nlm.nih.gov

Measurement of the Ratio of b Quark Production Cross Sections in Antiproton-Proton Collisions at 630 GeV and 1800 GeV

We report a measurement of the ratio of the bottom quark production cross section in antiproton-proton collisions at 630 GeV to 1800 GeV using bottom quarks with transverse momenta greater than 10.75 GeV identified through their semileptonic decays and long lifetimes. The measured ratio sigma(630)/sigma(1800) = 0.171 +/- .024 +/- .012 is in good agreement with next-to-leading order (NLO) quantum chromodynamics (QCD).
arxiv.org

Vacancy Engineering in Tungsten Oxide for Enhanced Temperature-Modulated Electrochromic Smart Windows.

High-temperature control depends on the modulation of visible (VIS) and near-infrared (NIR) radiation for a pleasant living environment. However, achieving a strong absorption of NIR light is still a challenge for electrochromic materials. In this work, a high NIR absorbance is achieved by Ag-doped tungsten oxide (Ag@WO
www.ncbi.nlm.nih.gov

Bilateral sequential accelerated theta-burst stimulation for treatment-resistant depression: an open-label randomized controlled trial.

This study aims to evaluate the clinical effectiveness and feasibility of a novel bilateral sequential accelerated theta-burst stimulation (BS-aTBS) protocol in treatment-resistant depression (TRD) patients, compared to a standard intermittent TBS (a-iTBS) protocol.
www.ncbi.nlm.nih.gov

Results From the Genetic Information and Family Testing Study: A Cluster-Randomized Trial.

Cascade genetic testing in families with hereditary cancer syndromes is an important strategy to reduce the burden of cancer, but testing of relatives is low. Direct engagement of relatives through cancer survivors is a promising approach to bridge this gap.
www.ncbi.nlm.nih.gov